H19 and glioblastoma: Given the cumulative evidence pointing to H19 as an oncogene in glioblastoma, in this work we aimed to unravel the molecular basis of this role, with a specific focus on its possible involvement in the epigenetic modulation of gene expression mediated by EZH2 binding and trimethylation of H3K27 at regulatory regions.